این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Basic Medical Sciences، جلد ۲۳، شماره ۱۱، صفحات ۱۳۷۴-۱۳۸۱
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Effect of Boswellia species on the metabolic syndrome: A review
چکیده انگلیسی مقاله The metabolic syndrome, a cluster of metabolic disorders, includes abdominal obesity, hypertension, dyslipidemia, and hyperglycemia leading to insulin resistance, development of diabetes mellitus, and cardiovascular diseases. For the treatment of metabolic syndrome, traditional herbal medicines such as frankincense or Boswellia species have been used due to their anti-inflammatory, anti-oxidant, anti-obesity, antidiabetic, antihypertensive, and hypolipidemic properties. Based on the literature, published evidence up to 2020 about the therapeutic effects of Boswellia species on the metabolic disorder among Medline, Scopus, and Google Scholar were precisely evaluated by keywords such as obesity, diabetes, hyperglycemia, hypertension, blood pressure, dyslipidemia, metabolic syndrome, frankincense, and Boswellia. According to the results, Boswellia species have beneficial effects to control metabolic syndrome and its related disorders such as hyperglycemia, dyslipidemia, hypertension, obesity, diabetes, and its complications. Boswellia species by reducing the resistance to insulin and restoring pancreatic beta cells decrease blood glucose. Also, Boswellia species has antithrombotic and anticoagulant properties that regulate blood pressure. The anti-oxidant properties of Boswellia species modulate the blood lipid profile via reducing TNF-α, IL-1β levels, and increasing the adiponectin level. The therapeutic and protective effects of Boswellia species on metabolic disorders were remarkably confirmed regarding decreasing hyperglycemia, hyperlipidemia, hypertension, and obesity.
کلیدواژه‌های انگلیسی مقاله Hyperglycemia, Hypertension, Dyslipidemia, metabolic syndrome, Frankincense, Olibanum, Boswellia
نویسندگان مقاله | Davoud Mahdian
Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran|Department of Pharmacology, School of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran


| Kazem Abbaszadeh-Goudarzi
Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran


| Amir Raoofi
Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran


| Ghazaleh Dadashizadeh
Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran


| Mina Abroudi
Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran


| Elahe Zarepour
Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran


| Hossein Hosseinzadeh
Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran|Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
نشانی اینترنتی https://ijbms.mums.ac.ir/article_16582.html
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Review Article
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات